Heteroaryl compounds and methods of use thereof
AssigneeSunovion Pharmaceuticals Inc.
InventorsJohn Emmerson Campbell, Michael Charles Hewitt, Philip Jones, Linghong Xie
Life of this patent
Estimating the term…
Abstract
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
Claims43
A compound of formula (I):
- A-L-B (I),
- or a pharmaceutically acceptable salt or stereoisomer thereof, wherein
- L is —C(R6)2—C(R6)2—, —C(R6)═C(R6) —, —N(R10) —C(R6)2—, —O—C(R6)2—, —C(R6)2—N(R10) —, —C(R6)2—O—, —C(R6)2—S—, —S—, —(CH2)p—S—(CH2)q—, or —(CH2)u—;
- A is
- B is
- -A1-A2- is —NR7—C(═O) —, —C(═O)—NR7—, —O—C(═O) —, —C(═O)—O—, —N═CR8—, —CR8═N—, —CR8═CR8—, or —N═N—;
- A3 is N or CR9;
- A4 is NR5, O, or S;
- A5 is CR5 or N;
- A6 is N or CR5;
- R1 and R2 are each independently (i) hydrogen, cyano, or halo;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)alkoxyl, (C1-C10)aminoalkyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered)heterocyclyl, hydroxyl, amino, imino, amido, carbonyl, thiol, sulfinyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- or (iii) R1 and R2 together with the carbon atoms to which they are attached form a ring optionally substituted with one or more R11;
- R3 and R4 are each independently (i) hydrogen, cyano, or halo;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)alkoxyl, (C1-C10)aminoalkyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered)heterocyclyl, hydroxyl, amino, imino, amido, carbonyl, thiol, sulfinyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- or (iii) R3 and R4 together with the atoms to which they are attached form a ring optionally substituted with one or more R11;
- R5 is (i) hydrogen, cyano, or halo;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)alkoxyl, (C1-C10)aminoalkyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered)heterocyclyl, hydroxyl, amino, imino, amido, carbonyl, thiol, sulfinyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- or (iii) R4 and R5 together with the atoms to which they are attached form a ring optionally substituted with one or more R11;
- R19 is (i) hydrogen, cyano, or halo;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)alkoxyl, (C1-C10)aminoalkyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered)heterocyclyl, hydroxyl, amino, imino, amido, carbonyl, thiol, sulfinyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- R20 is (i) hydrogen;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered)heterocyclyl, carbonyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- each occurrence of R6 is independently hydrogen, halo, or (C1-C6)alkyl optionally substituted with one or more halo;
- R7 is hydrogen or (C1-C6)alkyl optionally substituted with one or more halo;
- each occurrence of R8 is independently (i) hydrogen, cyano, or halo;
- or (ii) (C1-C10)alkyl, (C2-C10)alkenyl, (C1-C10)alkoxyl, (C1-C10)aminoalkyl, (C1-C10)heteroalkyl, (C3-C10)cycloalkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, (3 to 12 membered) heterocyclyl, hydroxyl, amino, imino, amido, carbonyl, thiol, sulfinyl, or sulfonyl, each of which is optionally substituted with one or more R11;
- R9 is hydrogen, cyano, halo, (C1-C6)alkyl optionally substituted with one or more halo, or (C1-C6)alkoxyl optionally substituted with one or more halo;
- R10 is hydrogen or (C1-C6)alkyl optionally substituted with one or more halo;
- each occurrence of R11 is independently hydrogen, halogen, cyano, ═O, —OR13, —NR13R14, —N(R13)C(O)R14, —C(O)NR13R14, —C(O)R13, —C(O)OR13, —OC(O)R13, —SR13, —S(O)R13, —S(O)2R13, —S(O)2NR13R14, C1-C10)alkyl optionally substituted with one or more R12, (C1-C10)heteroalkyl optionally substituted with one or more R12, (C3-C10)cycloalkyl optionally substituted with one or more R12, (C7-C12)aralkyl optionally substituted with one or more R12, (C3-C12)heteroaralkyl optionally substituted with one or more R12, (6 to 10 membered)aryl optionally substituted with one or more R12, (5 to 10 membered)heteroaryl optionally substituted with one or more R12, or (3 to 12 membered)heterocyclyl optionally substituted with one or more R12;
- each occurrence of R12 is independently hydrogen, (C1-C6)alkyl optionally substituted with one or more R13, (C3-C6)cycloalkyl optionally substituted with one or more R13, halogen, cyano, ═O, —OR13, —NR13R14, —N(R13)C(O)R14, —C(O)NR13R14, —C(O)R13, —C(O)OR13, —OC(O)R13, —SR13, —S(O)R13, —S(O)2R13, or —S(O)2NR13R14;
- each occurrence of R13 and R14 is independently hydrogen, (C1-C6)alkyl, (C1-C6) heteroalkyl, (C3-C6)cycloalkyl, (C7-C10)aralkyl;
- (C3-C12)heteroaralkyl, (6 to 10 membered)aryl, (5 to 10 membered)heteroaryl, or (3 to 12 membered)heterocyclyl;
- or R13 and R14 together may form a 3 to 10 membered ring;
- and
- u is 2 or 3;
- and
- p and q are each independently 0, 1, or 2, provided that when one of p and q is 0, the other is 1 or 2.
A compound, or a pharmaceutically acceptable salt or stereoisomer thereof, wherein the compound is:
45-48. (canceled)
Dependencies are inferred from the claim text.